Retatrutide Vigelan pre-filled pen 20 mg

Retatrutide Vigelan 20 mg — what is Retatrutide and why is it being studied

Do you constantly want to eat? Does it not last long? Is it difficult to control portions, do you crave sweets or food in the evening? Is your weight decreasing slowly or has it stopped at one indicator?

It is because of such inquiries that many people are becoming interested in modern directions of appetite and body weight control: GLP-1, semaglutide, tirzepatide, Mounjaro, and recently — the new research molecule Retatrutide.

Retatrutide Vigelan 20 mg — Pre-filled Pen format, containing Retatrutide in a pre-filled syringe pen.

What is Retatrutide in simple words

Retatrutide — an experimental molecule that is being studied in the field of obesity and metabolic health.

Its feature is the simultaneous activity towards three receptor systems:

GLP-1 + GIP + glucagon.

It is this triple mechanism that distinguishes Retatrutide from semaglutide and tirzepatide.

GLP-1 is associated with the regulation of appetite and satiety. GIP is involved in the body's metabolic response to food. Additional activity towards the glucagon receptor is one of the features of Retatrutide, which is currently being studied by researchers.

Why is Retatrutide compared to Mounjaro and Ozempic

A person who hears the name "retatrutide" for the first time often already knows about Ozempic, Wegovy, Mounjaro or Tirzepatide.

But these are not the same molecules.

Semaglutide is a GLP-1 agonist.

Tirzepatide is a dual agonist of GIP + GLP-1.

Retatrutide is being investigated as a triple agonist of GIP + GLP-1 + glucagon receptor.

Therefore, Retatrutide is not another name for Mounjaro or Ozempic, but a separate molecule under investigation.

Why does strong appetite occur and why weight can remain stable

Strong hunger, constant thoughts about food, cravings for sweets or the lack of prolonged satiety should not be automatically attributed only to “lack of willpower”.

Appetite and changes in body weight can be influenced by nutrition, sleep, physical activity, energy balance, medications and various physiological and metabolic factors.

Therefore, the search for “what to take so that you do not want to eat” should not replace an assessment of the causes of excessive appetite.

It is the regulation of appetite, satiety, energy balance and metabolism that are among the reasons for the great scientific interest in GLP-1/GIP drugs and Retatrutide.

Retatrutide for weight plateau

Another common query is “I’ve plateaued and won’t lose weight any more.”

A plateau can occur for many reasons, so stopping weight gain alone is not an indication for using any particular molecule.

Retatrutide is attracting attention precisely because of its triple mechanism of action, but its efficacy and safety continue to be evaluated in clinical trials.

Retatrutide Vigelan 20 mg Pre-filled Pen

Name: Retatrutide Vigelan

Brand: Vigelan

The Pre-filled Pen format means a pre-filled pen without the need for self-dilution.

Retatrutide or Tirzepatide — what’s the difference

These are different molecules.

Tirzepatide affects GIP + GLP-1, while Retatrutide is being studied as a triple agonist of GIP + GLP-1 + glucagon.

Therefore, it is wrong to consider Retatrutide simply as “a stronger Tirzepatide.” The difference lies primarily in the mechanism of action, and the issues of efficacy, tolerability and safety require separate assessment.

Retatrutide or Semaglutide - what is the difference

Semaglutide acts through the GLP-1 receptor.

Retatrutide is being studied with simultaneous activity towards GLP-1, GIP and glucagon receptors.

That is why Retatrutide is often called a triple agonist in the scientific literature.

Frequently asked questions about Retatrutide

What is Retatrutide?

Retatrutide is an investigational molecule with triple activity towards GLP-1, GIP and glucagon receptors.

Are Retatrutide and tirzepatide the same thing?

No. Tirzepatide and Retatrutide are different molecules. Tirzepatide has a dual, while Retatrutide is being studied with a triple mechanism of action.

Is Retatrutide Mounjaro?

No. The active ingredient in Mounjaro is tirzepatide. Retatrutide is another investigational molecule.

Is Retatrutide the same as Ozempic?

No. Ozempic contains semaglutide. Retatrutide has a different mechanism of action.

Is Retatrutide being investigated for weight loss?

Yes. The molecule is being investigated, in particular, in clinical programs for obesity and related metabolic conditions.

What does Retatrutide Pre-filled Pen mean?

Pre-filled Pen refers to a pre-filled pen format.

Is Retatrutide approved?

As of 2026, Retatrutide remains an investigational molecule and is not an FDA-approved drug for general use.